BIOTEC and Asia Star Animal Health Co., Ltd. (ASAH) signed a licensing agreement to facilitate the transfer of feed enzyme technology developed by Bioresources Technology Unit to the company for commercial production. The technology, derived from a collaborative research between BIOTEC and ASAH, includes the new fungal strain, Aspergillus sp., which was screened from BIOTEC Culture Collection and the solid state fermentation technique for enzyme production.
This new fungal strain is capable of producing high level of multi-enzyme complex, mainly carbohydrases, with high stability under low pH condition.
Representing BIOTEC and ASAH at the signing ceremony were Dr. Kanyawim Kirtikara, BIOTEC Executive Director and Mr. Krit Chockpipatphol and Ms. Prapaisri Phisitkul, Managing Directors of ASAH.
BIOTEC and ASAH has been collaborating in research and technology transfer since 2008. This is their third licensing agreement. The first two agreements have brought an assortment of feed products to the market New product using this newly acquired technology will be launched next year, according to Mr. Krit Chockpipatphol.
“The success of our products has led an expansion of our enzyme production factory, which is partially financed through NSTDA soft-loan program for companies investing in technology development. The new factory is expected to be opened early 2014,” added Mr. Krit.
ASAH is a veterinary medicine company that was found with the philosophy of sustainable development in agriculture industry. ASAH occupied predominantly in research and development, manufacturer and sales of high quality products and therapy systems.